Evidence map›Paper›PMID 40076217›Full record

ArticleMolecules (Basel, Switzerland)2025

Simultaneous Isolation and Purification of Transferrin and Immunoglobulin G from Human Serum-A New Biotech Solution.

Danilo Četić, Goran Miljuš, Zorana Dobrijević, Nikola Gligorijević, Aleksandra Vilotić, Olgica Nedić, Ana Penezić

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Danilo ČetićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.ORCID 0000-0001-9705-3237
Goran MiljušInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.
Zorana DobrijevićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.ORCID 0000-0002-4652-7719
Nikola GligorijevićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.ORCID 0000-0002-8691-2486
Aleksandra VilotićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.
Olgica NedićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.ORCID 0000-0003-2042-0056
Ana PenezićInstitute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31 b, 11000 Belgrade, Serbia.ORCID 0000-0002-2539-4507

Funding

Ministry of Education, Science and Technological development of the Republic of Serbia 451-03-47/2023-01/ 200019
6 · The paper itself

Abstract

A fast and simple biotech method is presented for the simultaneous isolation and purification of transferrin (Tf) and immunoglobulin G (IgG) from the same pool-sample of human serum, yielding >98% pure proteins. Serum sample preparation was achieved by precipitation with ethacridine lactate (rivanol). Protein purification was performed with AKTA Avant 150 FPLC, using a Resource Q column. Three different buffers at pH 6.2 (MES, phosphate, and Bis-Tris) were tested. Isolated and purified proteins retained their native 3D structure, as shown by spectrofluorimetric measurements. Tf functionality was preserved, as confirmed by the retention of both the iron binding capacity and its ability to interact with the transferrin receptor (immunofluorescent staining), as well as the immunogenicity of IgG, as shown by Western blot analysis with immunodetection. The formation of IgG aggregates was avoided. This biotech method is a rapid, simple, and time-saving alternative to other methods for the isolation of extremely pure IgG and Tf, while it is also the only method so far described for their simultaneous isolation.

Indexed as

BiotechnologyImmunoglobulin GTransferrinHumansImmunoglobulin GTransferrinbiotherapeuticsIgGion-exchangeisolation and purificationtransferrin

Identifiers

PMID40076217
PMCPMC11901732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.